Home > > Middle East & Africa And Global Liver Disease Diagnostics Market- Size, Share, Growth Rate, and Forecast
The Middle East & Africa Liver Disease Diagnostics market was valued at $5,023.3 Million in 2023, and is projected to reach $7,719.6 Million by 2030 growing at a CAGR of 6.38% from 2024 to 2030. Imaging segment is expected to be the highest contributor to this market, with $1,476.4 Million in 2023, and is anticipated to reach $2,018.5 by 2030, registering a CAGR of 4.61%. Laboratory tests segment is anticipated to reach $1,492.6 Million by 2030 with the highest CAGR of 8.77%. Imaging and Biopsy segments collectively expected to account for about 52.7% share of the Middle East & Africa Liver Disease Diagnostics market in 2023, with the former constituting around 29.4% share. Laboratory tests and Endoscopy segments are expected to witness significant growth rates at a CAGR of 8.77% and 7.68% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 36.3% in the overall Middle East & Africa Liver Disease Diagnostics market in 2023, and is anticipated to reach 40.9% by 2030. Diagnosis Technique Imaging Laboratory tests Endoscopy Biopsy Other Diagnosis Techniques End-Use Hospitals Laboratories Other End Uses BY REGION North America U.s. Canada Europe Germany U.k. France Italy Spain Rest of Europe Asia China Japan South Korea India Indonesia Rest of Asia Middle East & Africa Brazil Mexico South Africa Australia Rest of MENA